Compare Ferrari NV (RACE) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ferrari NV vs Summit Therapeutics Inc — how do they compare? Ferrari NV trades at $371.61 (market cap $65.25B), while Summit Therapeutics Inc trades at $14.78 (market cap $11.34B). The key difference: Ferrari NV is far larger — about 5.8× Summit Therapeutics Inc's market cap, and Ferrari NV pays a 1.14% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| RACE | SMMT | |
|---|---|---|
Market Cap | $65.25B | $11.34B |
Sector | Consumer Cyclical | Health |
52-Week High | $517.65 | $29.32 |
52-Week Low | $314.63 | $13.05 |
Enterprise Value | $66.46B | $10.76B |
Dividend Yield | 1.14% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ferrari NV
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
